Leverages Innovative Technologies, Personalized Approach for Medication-free Treatment Options Medford, N.Y., – September 9, 2020 — Long Island NeuroCare Therapy, the flagship neuroCare Centers of
neuroCare and Kyowa sign an equity participation paving the way for a strategic joint venture in Japan neuroCare Group GmbH (“neuroCare”) personalizes mental health therapy
Become a NeuroStar – watch this video and see why NeuroStar can help make long-term remission from depression possible. Contact us today for TMS Therapy!
A study published recently in the American Journal of Epidemiology found that a strong association between even low-level nighttime light exposure and depressive symptoms among
While acknowledging that treatment with medication for attention deficit hyperactivity disorder (ADHD) is effective in the short term, researchers of a meta-analysis literature review have
Researchers compare methods of treating ADHD in children and find that Neurofeedback, a medication-free technique, has long-lasting effects up to 12 months A study just
Researchers compare costs of rTMS treatment with antidepressant medication, factoring in financial costs and quality of life. Repetitive Transcranial Magnetic Stimulation is an effective and
Abstract Neurofeedback (NF) has gained increasing interest in the treatment of attention-de cit/hyperactivity disorder (ADHD). Given learning principles underlie NF, lasting clinical treatment effects may
Sleep expert Matthew Walker breaks down the many effects of sleep deprivation on your brain and body. Following is a transcript of the video. Matthew
© 2020 All rights reserved
Click the link above to continue or CANCEL
